The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 21, 2017
Filed:
Jun. 15, 2012
Applicants:
Björn Scheffler, Bonn, DE;
Martin Glas, Bonn, DE;
Matthias Simon, Bonn, DE;
Sabine Gogolok, Hagen, DE;
Daniel Trageser, Bonn, DE;
Roman Reinartz, Bonn, DE;
Anja Wieland, Wachtberg, DE;
Inventors:
Björn Scheffler, Bonn, DE;
Martin Glas, Bonn, DE;
Matthias Simon, Bonn, DE;
Sabine Gogolok, Hagen, DE;
Daniel Trageser, Bonn, DE;
Roman Reinartz, Bonn, DE;
Anja Wieland, Wachtberg, DE;
Assignees:
Life & Brain GmbH, Bonn, DE;
Rheinische Friedrich-Wilhelms Universitat, Bonn, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 493/06 (2006.01); C07D 493/18 (2006.01); A61K 31/352 (2006.01); G01N 33/574 (2006.01); A61K 31/4188 (2006.01);
U.S. Cl.
CPC ...
C07D 493/18 (2013.01); A61K 31/352 (2013.01); A61K 31/4188 (2013.01); C07D 493/06 (2013.01); G01N 33/57492 (2013.01); G01N 2333/70596 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention relates to glioblastoma inhibiting compounds, in particular gambogic acid amid and derivatives thereof for the treatment of glioblastoma. Moreover, methods for determining whether a treatment with the compounds of the invention is suitable for a patient are disclosed.